Nephros (NEPH) Net Cash Flow (2010 - 2026)

Nephros' Net Cash Flow history runs 17 years deep, the most recent figure standing at -$1.4 million for Q1 2026.

• On a quarterly basis, Net Cash Flow fell 530.53% year-over-year to -$1.4 million in Q1 2026; TTM through Mar 2026 was -$108000.0, a 121.69% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, up 391.59% from the prior year.
• Net Cash Flow retreated to -$1.4 million in Q1 2026 per NEPH's latest filing, from $184000.0 in the prior quarter.
• Across five years, Net Cash Flow topped out at $1.3 million in Q4 2024 and bottomed at -$1.5 million in Q1 2022.
• The 5-year median for Net Cash Flow is -$239000.0 (2022), against an average of -$169000.0.
• Across the five-year window, Net Cash Flow plunged 1813.58% in 2022 and jumped 572.1% in 2024, its largest moves.
• Year by year, Net Cash Flow stood at -$306000.0 in 2022, then advanced by 9.8% to -$276000.0 in 2023, then soared by 572.1% to $1.3 million in 2024, then slumped by 85.88% to $184000.0 in 2025, then slumped by 851.09% to -$1.4 million in 2026.
• Per Business Quant, the three latest NEPH Net Cash Flow figures stand at -$1.4 million (Q1 2026), $184000.0 (Q4 2025), and $97000.0 (Q3 2025).